EQUILLIUM, INC. Operating Cash Flow
EQUILLIUM, INC. (EQ) reported Operating Cash Flow of -$8.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- EQUILLIUM, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.11M.
- EQUILLIUM, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.30M.
- EQUILLIUM, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.13M.
- EQUILLIUM, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$8.43M.
- EQUILLIUM, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$22.75M.
- EQUILLIUM, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$19.03M.
- EQUILLIUM, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$21.78M.
- EQUILLIUM, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$8.73M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$8.41M 10-Q · filed 2026-08-13 | -$11.54M derived: sum of 3 quarters · filed 2026-08-13 | -$19.97M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$4.30M 10-Q · filed 2026-05-13 | -$7.43M derived: sum of 2 quarters · filed 2026-05-13 | -$15.87M derived: sum of 3 quarters · filed 2026-05-13 | -$18.88M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$11.56M derived: sum of 2 quarters · filed 2026-03-25 | -$14.58M derived: sum of 3 quarters · filed 2026-08-13 | -$22.75M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$8.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$11.44M derived: sum of 2 quarters · filed 2026-08-13 | -$19.61M 10-Q · filed 2025-11-13 | -$22.91M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$11.18M 10-Q · filed 2026-08-13 | -$14.48M derived: sum of 3 quarters · filed 2026-08-13 | -$22.14M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$8.17M 10-Q · filed 2026-05-13 | -$11.47M derived: sum of 2 quarters · filed 2026-05-13 | -$19.13M derived: sum of 3 quarters · filed 2026-05-13 | -$18.39M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$10.96M derived: sum of 2 quarters · filed 2026-03-25 | -$10.23M derived: sum of 3 quarters · filed 2026-03-25 | -$19.03M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$7.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$6.93M derived: sum of 2 quarters · filed 2025-11-13 | -$15.73M 10-Q · filed 2025-11-13 | -$21.39M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $730.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$8.07M 10-Q · filed 2025-08-14 | -$13.73M derived: sum of 3 quarters · filed 2025-08-14 | -$15.64M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$8.80M 10-Q · filed 2025-05-14 | -$14.46M derived: sum of 2 quarters · filed 2025-05-14 | -$16.37M derived: sum of 3 quarters · filed 2025-05-14 | -$22.59M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$7.57M derived: sum of 2 quarters · filed 2025-03-27 | -$13.79M derived: sum of 3 quarters · filed 2025-03-27 | -$21.78M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$8.12M derived: sum of 2 quarters · filed 2024-11-13 | -$16.12M 10-Q · filed 2024-11-13 | $11.61M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$6.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$14.21M 10-Q · filed 2024-08-08 | $13.52M derived: sum of 3 quarters · filed 2024-08-08 | $450.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$8.00M 10-Q · filed 2024-05-09 | $19.73M derived: sum of 2 quarters · filed 2024-05-09 | $6.67M derived: sum of 3 quarters · filed 2024-05-09 | -$4.59M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $27.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $14.66M derived: sum of 2 quarters · filed 2024-03-25 | $3.40M derived: sum of 3 quarters · filed 2024-03-25 | -$8.73M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | -$13.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$24.32M derived: sum of 2 quarters · filed 2023-11-08 | -$36.46M 10-Q · filed 2023-11-08 | -$46.59M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$11.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$23.39M 10-Q · filed 2023-08-09 | -$33.53M derived: sum of 3 quarters · filed 2023-08-09 | -$40.54M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$12.13M 10-Q · filed 2023-05-11 | -$22.27M derived: sum of 2 quarters · filed 2023-05-11 | -$29.28M derived: sum of 3 quarters · filed 2023-05-11 | -$36.27M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$10.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$17.14M derived: sum of 2 quarters · filed 2023-03-23 | -$24.14M derived: sum of 3 quarters · filed 2023-03-23 | -$32.08M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$7.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$14.00M derived: sum of 2 quarters · filed 2022-11-14 | -$21.95M 10-Q · filed 2022-11-14 | -$30.20M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$6.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$14.94M 10-Q · filed 2022-08-15 | -$23.19M derived: sum of 3 quarters · filed 2022-08-15 | -$28.11M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$7.94M 10-Q · filed 2022-05-12 | -$16.20M derived: sum of 2 quarters · filed 2022-05-12 | -$21.12M derived: sum of 3 quarters · filed 2022-05-12 | -$26.20M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$8.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$13.17M derived: sum of 2 quarters · filed 2022-03-23 | -$18.25M derived: sum of 3 quarters · filed 2022-03-23 | -$24.62M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | -$4.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$10.00M derived: sum of 2 quarters · filed 2021-11-10 | -$16.37M 10-Q · filed 2021-11-10 | -$25.40M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$5.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$11.45M 10-Q · filed 2021-08-10 | -$20.48M derived: sum of 3 quarters · filed 2021-08-10 | -$25.18M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | -$6.37M 10-Q · filed 2021-05-13 | -$15.40M derived: sum of 2 quarters · filed 2021-05-13 | -$20.10M derived: sum of 3 quarters · filed 2021-05-13 | -$24.86M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$13.73M derived: sum of 2 quarters · filed 2021-03-24 | -$18.48M derived: sum of 3 quarters · filed 2021-03-24 | -$22.95M 10-K · filed 2021-03-24 | ||||
| 2019-09-30 | -$4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$9.45M derived: sum of 2 quarters · filed 2020-11-10 | -$13.92M 10-Q · filed 2020-11-10 | -$17.74M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | -$4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$9.22M 10-Q · filed 2020-08-12 | -$13.05M derived: sum of 3 quarters · filed 2020-08-12 | -$14.69M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | -$4.46M 10-Q · filed 2020-05-13 | -$8.29M derived: sum of 2 quarters · filed 2020-05-13 | -$9.93M derived: sum of 3 quarters · filed 2020-05-13 | -$11.10M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | -$3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$5.47M derived: sum of 2 quarters · filed 2020-03-26 | -$6.64M derived: sum of 3 quarters · filed 2020-03-26 | -$7.53M 10-K · filed 2020-03-26 | -$7.53M 10-K · filed 2019-03-27 | |||
| 2018-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$2.81M derived: sum of 2 quarters · filed 2019-11-12 | -$3.70M 10-Q · filed 2019-11-12 | -$3.70M 10-Q · filed 2018-11-15 | ||||
| 2018-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$2.06M 10-Q · filed 2019-08-12 | ||||||
| 2018-03-31 | -$889.00K 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | -$662.20K 10-K · filed 2019-03-27 | |||||||
| 2017-09-30 | -$267.42K 10-Q · filed 2018-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |